FEATURE ARTICLES
Meeting healthcare needs: developing an MSc for point-of-care testing
Course leader Dr Sean Brown and tutor Robyn Wilson describe the development and content of Abertay University’s new Biomedical Sciences with Point-of-Care Testing MSc.
Rethinking emergency cardiac care: challenging the status quo
A novel high-sensitivity troponin point-of-care test has the potential to have a positive impact on accident and emergency departments. Professor Paul Collinson discusses how this new technology could help the NHS, and his involvement in a study evaluating it.
Anaplastic large cell lymphoma: an association with breast implants
Although rare in occurrence, breast implant-associated anaplastic large-cell lymphoma recently found its way into the national news. Here, Pathology in Practice Science Editor Brian Nation compiles a selection of current research interest in this iatrogenic disease.
New system offers consistent, optimal IHC staining results
With increasing demands for advanced immunohistochemistry staining, a new system promises to deliver consistent, standardised results via a closed workflow which also places fewer demands on an already stretched laboratory workforce.
Why UK NEQAS is here – education, education, education!
Sharing knowledge is the key to more accurate laboratory testing, and also for longer-term, better patient outcomes. Scheme Directors Melody Tabiner and Richard Haggas reveal the many and varied ways in which UK NEQAS shares its expert knowledge.
Osmolality and beyond: delivering innovation for nearly 70 years
Building innovative solutions to common laboratory challenges has been Advanced Instruments’ mission since 1955, a time when electronic automation was just beginning to be applied to laboratory methods. Throughout its 70-year history, Advanced Instruments’ osmometers have helped global clinical laboratories revolutionise workflow efficiency on the chemistry bench. Over the last two decades, this mission has expanded to microbiology, haematology, and beyond.
Unseen risks: how MU affects much more than just assays
In this final article in his latest series, Stephen MacDonald concludes by focusing on the importance of uncertainty measurement outside the narrow boundary of analytical process, into the wider realm of equipment calibration, monitoring and performance.
Utilising genetic risk scores to predict and identify type 1 diabetes
The recent development of disease-modifying therapies for type 1 diabetes, coupled with increased difficulty in diagnosing diabetes subtypes is reinforcing the need for accurate and cost-effective methods of identifying those at risk of developing the disease. Genetic risk scores may provide novel methods to help identify those at risk and to improve discrimination between subtypes of diabetes.
Putting patients at the heart of phlebotomy booking services
Warrington and Halton Teaching Hospitals NHS Foundation Trust has transformed the service it offers to GPs and patients for phlebotomy appointments by deploying two key innovative technologies that make the whole process paperless.
Whooping cough, the resurgence of a vaccine preventable disease
Dr Neil Bentley looks at the history, causes and treatment of whooping cough, as well as examining the vaccine issues which may have contributed to a recent resurgence of the condition in many countries around the world.
Responding to challenges, realising opportunities: Clinisys Customer Summit
Clinisys WinPath laboratory information system customers recently gathered at The Belfry to discuss the major challenges facing pathology, and the role of technology in addressing them. Here, Matthew Fouracre reports from a packed, but inspiring, two-day event.
Neisseria gonorrhoeae: an STI that has developed resistance mechanisms to antimicrobials
Last year, over 85,000 gonorrhoea diagnoses were reported in England, the highest number since records began in 1918. Here, Pathology in Practice Science Editor Brian Nation compiles a selection of current research interest focusing on AMR in this sexually transmitted infection.
Why UK NEQAS does what it does: it’s all about the patients
Dr Deborah Pritchard and Dr Gwen Wark, members of the UK NEQAS Board, explain how UK NEQAS gives users the confidence that they are providing the best results for their assays, and clinical teams and patients the reassurance that they are receiving the correct information to manage health conditions and treatment.
Revolutionising laboratories with sthemO and sthemE haemostasis systems
Stago’s new high-throughput sthemO and sthemE haemostasis systems deliver better patient care, improve productivity, and reduce staff pressure – making them the ideal solutions for addressing urgent NHS coagulation laboratory challenges.
Reviewing and reporting measurement uncertainty in medical laboratories
In this penultimate article in his current series, Stephen MacDonald focuses on the vital role that each stakeholder plays in ensuring compliance with measurement uncertainty limits and enhancing the overall quality of laboratory services.
Improvements to laboratory process through a molecular work area
Karl McIntyre of Liverpool Clinical Laboratories describes the improvements to pathology process and efficiency which have been delivered by a fully automated molecular work area.
Measurement uncertainty in results with no numbers: an overview
In this sixth article in his series, Stephen MacDonald looks at the widespread use of semi-quantitative assays where more research and discussion is needed into how to apply statistical approaches to their measurements, and the impact that has on clinical decision-making.
Rapid diagnostics – warts and all: a report on the fight against AMR
In this second report from this year’s British Society for Microbial Technology Annual Microbiology Conference, BSMT Chair Dr Mark Wilks and colleagues look at three further presentations, all of which focus on and illustrate issues related to antimicrobial resistance.
Bordetella pertussis infection: testing for the re-emergence of whooping cough
Despite the high vaccination coverage in developed countries, Bordetella pertussis infection is considered a re-emerging disease that is underreported and underdiagnosed. Here, Pathology in Practice Science Editor Brian Nation compiles a selection of research interest.
Is manual cell counting in CSF specimens a thing of the past?
Cerebrospinal fluid cell counts performed using haemocytometer chamber methods are prone to high interobserver variability and poor reproducibility. Utilising an automated system minimises errors and simplifies the testing process.
Latest Issues
Verulam Scientific Ltd is an analytical instrument company providing innovative solutions and emerging technologies to the UK pharmaceutical, environmental, life science, food, clinical and biotechnology markets. We provide laboratories with the equipment and services that are crucial to modern analytical services and research.
Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo
Hyatt Regency, Vancouver, Canada
19-23 November, 2024
11th Digital Pathology & AI Congress: Europe
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Microbiology Society Annual Conference 2025
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
BSMT Annual Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Ghent Pathology 2025
ICC Ghent, Belgium
24-26 June, 2025